Biofrontera (BFRI) Total Current Liabilities (2020 - 2026)
Biofrontera (BFRI) posted quarterly Total Current Liabilities of $11.9 million for Q4 2025, down 1.05% year-over-year from $12.0 million in Q4 2024, and down 5.24% quarter-over-quarter from $12.6 million in Q3 2025.
Biofrontera (BFRI) Total Current Liabilities (2020 - 2026) Analysis & Trends
Biofrontera's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $11.9 million for Q4 2025.
- In Q4 2025, Total Current Liabilities fell 1.05% year-over-year to $11.9 million; the TTM figure through Dec 2025 stood at $11.9 million (down 1.05% YoY), while the FY2025 annual figure was $11.9 million, down 1.05% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $11.9 million, down from $12.6 million in the prior quarter.
- The five-year high for Total Current Liabilities was $29.1 million in Q3 2023, with the low at $9.3 million in Q2 2024.
- The 5-year median for Total Current Liabilities is $13.8 million (2021), against an average of $15.3 million.
- The sharpest annual moves came in 2021 and 2024: Total Current Liabilities surged 213.03% in 2021, then tumbled 62.12% in 2024.
- Biofrontera's Total Current Liabilities stood at $13.8 million in 2021, then surged by 51.01% to $20.9 million in 2022, then fell by 13.43% to $18.1 million in 2023, then sank by 33.54% to $12.0 million in 2024, then declined by 1.05% to $11.9 million in 2025.
- Business Quant data shows BFRI's Total Current Liabilities at $11.9 million in Q4 2025, $12.6 million in Q3 2025, and $19.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.79 Bn |
| 10 | Biofrontera | 18.87 Mn | 14.16 Mn | 9.59 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.54 Mn |
| Dec 31, 2025 | 11.90 Mn |
| Sep 30, 2025 | 12.55 Mn |
| Jun 30, 2025 | 19.69 Mn |
| Mar 31, 2025 | 10.96 Mn |
| Dec 31, 2024 | 12.02 Mn |
| Sep 30, 2024 | 11.03 Mn |
| Jun 30, 2024 | 9.27 Mn |
| Mar 31, 2024 | 14.04 Mn |
| Dec 31, 2023 | 18.09 Mn |
| Sep 30, 2023 | 29.12 Mn |
| Mar 31, 2023 | 20.45 Mn |
| Dec 31, 2022 | 20.89 Mn |
| Sep 30, 2022 | 17.14 Mn |
| Jun 30, 2022 | 14.88 Mn |
| Mar 31, 2022 | 12.36 Mn |
| Dec 31, 2021 | 13.84 Mn |
| Sep 30, 2021 | 11.29 Mn |
| Dec 31, 2020 | 4.42 Mn |